Evidence map›Paper›PMID 39198838›Full record

ArticleJournal of experimental & clinical cancer research : CR2024

Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.

Muhlis Akman, Ciro Monteleone, Gabriella Doronzo, Martina Godel, Francesca Napoli, Alessandra Merlini, Virginia Campani, Valeria Nele, Elisa Balmas, Tatiana Chontorotzea and 15 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Muhlis AkmanDepartment of Oncology, University of Torino, Torino, Italy.
Ciro MonteleoneDepartment of Oncology, University of Torino, Torino, Italy.
Gabriella DoronzoDepartment of Oncology, University of Torino, Torino, Italy.
Martina GodelDepartment of Oncology, University of Torino, Torino, Italy.
Francesca NapoliPathology Unit, Department of Oncology at San Luigi Hospital, University of Torino, Torino, Italy.
Alessandra MerliniThoracic Oncology Unit, Department of Oncology at San Luigi Hospital, University of Torino, Torino, Italy.
Virginia CampaniDepartment of Pharmacy, University of Napoli Federico II, Napoli, Italy.
Valeria NeleDepartment of Pharmacy, University of Napoli Federico II, Napoli, Italy.
Elisa BalmasDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Tatiana ChontorotzeaCenter for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Simona FontanaDepartment of Oncology, University of Torino, Torino, Italy.
Sabrina DigiovanniDepartment of Oncology, University of Torino, Torino, Italy.
Francesca Alice BarbuPathology Unit, Department of Oncology at San Luigi Hospital, University of Torino, Torino, Italy.
Elena AstaninaCandiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
Niloufar JafariDepartment of Oncology, University of Torino, Torino, Italy.
Iris Chiara SalaroglioDepartment of Oncology, University of Torino, Torino, Italy.
Joanna KopeckaDepartment of Oncology, University of Torino, Torino, Italy.
Giuseppe De RosaDepartment of Pharmacy, University of Napoli Federico II, Napoli, Italy.
Thomas MohrCenter for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Alessandro BerteroDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Luisella RighiPathology Unit, Department of Oncology at San Luigi Hospital, University of Torino, Torino, Italy.
Silvia NovelloThoracic Oncology Unit, Department of Oncology at San Luigi Hospital, University of Torino, Torino, Italy.
Giorgio Vittorio ScagliottiThoracic Oncology Unit, Department of Oncology at San Luigi Hospital, University of Torino, Torino, Italy.
Federico BussolinoDepartment of Oncology, University of Torino, Torino, Italy.
Chiara RigantiDepartment of Oncology, University of Torino, Torino, Italy. chiara.riganti@unito.it.ORCID http://orcid.org/0000-0001-9787-4836

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39198838
PMCPMC11360497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.